• Applications & Products
  • Media Formulation
  • About InVitria
  • Contact Us
  • Terms
  • Privacy
  • Sitemap
Performance. Defined.
  • 1-800-916-8311 or Email Us
  • iconMy Account
  • iconView Cart
  • Applications & Products
    • Applications
      • Gene Therapy
      • Cell Therapy
      • T-Cell Immunotherapy
      • Vaccine Production
      • Antibody Production
      • Final Formulation
      • Food Science
    • Product Types
      • Blood-Free Cell Culture Media
      • Cell Culture Components
      • Insulin-Transferrin Supplements
      • Recombinant Albumin
      • Recombinant Transferrin
      • Recombinant Lysozyme
    • Products
      • Cellastim S – Recombinant human albumin
      • Exbumin™ – Recombinant human albumin excipient
      • Optibumin – Recombinant human albumin
      • Optiferrin – Recombinant human transferrin
      • Lacromin – Recombinant human holo lactoferrin
      • ITS AF – Blood-free cell culture media supplement
      • ITSE + A – Blood-free cell culture media supplement
      • ITSE AF® – Blood-free cell culture media supplement
      • Lysobac – Recombinant human lysozyme
      • LysoSure – Recombinant lysozyme
      • Leukemia Inhibitory Factor
      • OptiPEAK® HEK293t
      • OptiPEAK® T Lymphocyte
      • OptiVERO®
  • Media Formulation
  • About InVitria
  • News & Blog
  • Contact Us
  • Applications
  • Products
  • Contact Us
  • Home
  • WEBINAR: The Cell Culture Revolution: Commercializing Therapeutic Cell Systems

WEBINAR: The Cell Culture Revolution: Commercializing Therapeutic Cell Systems

Published on 9 September 2018

Randy Alfano Ph.D.

{{cta(‘9927388d-1769-48eb-8289-dd017a248fc9’)}}

We are pleased to announce that on Tuesday, September 18th InVitria will be hosting a webinar in partnership with Genetic Engineering & Biotechnology News!

Here is the webinar abstract:

The advent of recombinant antibody production in mammalian cell lines has revolutionized modern medicine. Clinical success of these agents has challenged the underlying biological manufacturing systems to produce quantities sufficient to supply the ever-expanding commercial markets. 

A fundamental focus for commercialization efforts was optimization of cell culture media components utilized in the biologic manufacturing process. With primary and stem cell applications poised to make similar strides in clinical progress as monoclonal antibodies did in the 1990s, manufacturing methodologies must progress in parallel to ensure the clinical success of these novel cell-based therapeutics. In this GEN webinar, we will discuss the current state of the cell culture media space for primary and stem cell expansion. Moreover, we will discuss the reagents and development strategies needed to remove serum-derived proteins from media formulations to produce chemically defined and blood component free, or blood-free, expansion processes for therapeutic cell types.

A live Q&A session will follow the webinar, don’t forget to sign up today!

{{cta(‘e86eebf2-2157-4641-b424-c5418c403b0c’,’justifycenter’)}}

Start New Search

Quick Search Links

Application:

Antibody Production

Cell Therapy

Final Formulation

Food Science

Gene Therapy

T-Cell Immunotherapy

Vaccine Production

Product Category:

Cell Culture Supplements

Albumin

Cell Culture Media

Lactoferrin

LIF

Lysozyme

Single Components

Transferrin

Product:

Cellastim S® – Recombinant human albumin

Exbumin™ – Recombinant human albumin excipient

ITS AF® – Blood-free cell culture media supplement

ITSE + A® – Blood-free cell culture media supplement

ITSE AF® – Blood-free cell culture media supplement

Lacromin® – Recombinant human holo-lactoferrin

Leukemia Inhibitory Factor

Lysobac® – Recombinant human lysozyme

LysoSure® – Recombinant lysozyme

Optibumin® – Recombinant human albumin

Optiferrin® – Recombinant human transferrin

OptiPEAK® HEK293t

OptiPEAK® T Lymphocyte

OptiVERO®

Document Type:

Application Notes

Blog

Interviews

Journal Articles (DOI Links)

News

Posters

Product Brochures

Product Specifications

SDS

Use Guidelines

Webinar

White Papers

Cell Line:

B Lymphocyte

CHO

ESC

HEK293

Hematopoetic Stem Cells

Hybridoma

iPSC

Mesenchymal Stem Cells

Natural Killer Cells

Neural Stem Cells

T Lymphocyte

VERO

  • 2718 Industrial Drive • Junction City, KS 66441
  • 800-916-8311
  • © 2021 InVitria

    • Terms
    • Privacy
    • Sitemap